The Cancer Genome Characterization Initiatives (CGCI) program supports cutting-edge genomics research of adult and pediatric cancers. CGCI investigators develop and apply advanced sequencing methods that examine genomes, exomes, and transcriptomes within various types of tumors. The program includes Burkitt Lymphoma Genome Sequencing Project (BLGSP) project and HIV+ Tumor Molecular Characterization Project - Cervical Cancer (HTMCP-CC) project. The dataset contains open Clinical Supplement, Biospecimen Supplement, RNA-Seq Gene Expression Quantification, miRNA-Seq Isoform Expression Quantification, and miRNA Expression Quantification data. This dataset also contains controlled WGS/Targeted Sequencing/RNA-Seq/miRNA-Seq Aligned Reads, and RNA-Seq Splice Junction Quantification
Genomic Data Commons (GDC) is source of truth for this dataset; GDC offers monthly data releases, although this dataset may not be updated at every release.
NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies
See all datasets managed by Center for Translational Data Science at The University of Chicago.
Cancer Genome Characterization Initiatives - Burkitt Lymphoma, HIV+ Cervical Cancer was accessed on
DATE from https://registry.opendata.aws/cgci.
aws s3 ls --no-sign-request s3://gdc-cgci-blgsp-phs000235-2-open/
aws s3 ls --no-sign-request s3://gdc-cgci-phs000235-2-open/